• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Darius Juškevičius, Thomas Lorber, +5 authors Alexandar Tzankov
  • Biology, Medicine
  • Leukemia
  • 2016 (First Publication: 20 May 2016)
  • Recurrences of diffuse large B-cell lymphomas (DLBCL) result in significant morbidity and mortality, but their underlying genetic and biological mechanisms are unclear. Clonal relationship in DLBCLExpand
  • Cristina Viganó, Conrad von Schubert, +7 authors Erich A. Nigg
  • Biology, Medicine
  • Molecular biology of the cell
  • 2018 (First Publication: 1 May 2018)
  • This study analyzes the proteomes and phospho-proteomes of isogenic DLD-1 cancer cells differing in karyotypes and chromosome stability. Chromosome doubling is shown to trigger more extensive changesExpand
  • Darius Juškevičius, Tanja Dietsche, +6 authors Alexandar Tzankov
  • Medicine, Biology
  • Histopathology
  • 2014 (First Publication: 1 November 2014)
  • AIMS Primary effusion lymphoma (PEL) is a rare form of aggressive B-cell lymphoma, which typically manifests as malignant effusion in the body cavities. However, extracavitary solid variants are alsoExpand
  • Joël R Federer-Gsponer, Cristina Quintavalle, +11 authors Christian Ruiz
  • Medicine, Biology
  • The Journal of pathology
  • 2018 (First Publication: 1 May 2018)
  • Understanding the evolutionary mechanisms and genomic events leading to castration-resistant (CR) prostate cancer (PC) is key to improve the outcome of this otherwise deadly disease. Here, weExpand
  • Julia Kneißl, Anja Hartmann, +6 authors Birgit Luber
  • Medicine, Biology
  • Journal of Cancer Research and Clinical Oncology
  • 2016 (First Publication: 8 December 2016)
  • PurposeGastric cancer remains a major health concern, and improvement of the therapeutic options is crucial. Treatment with targeted therapeutics such as the EGFR-targeting antibody cetuximab or theExpand
  • Thomas Lorber, Noemi Andor, +11 authors Lukas Bubendorf
  • Biology, Medicine
  • The Journal of pathology
  • 2019 (First Publication: 1 February 2019)
  • Variable tumor cellularity can limit sensitivity and precision in comparative genomics because differences in tumor content can result in misclassifying truncal mutations as region-specific privateExpand